greeksoup/ stock research
Stock research / United States / TECH / FY2009

Bio-Techne (TECH) FY2009 results: revenue $264 million

Bio-Techne Corp. (TECH) reported revenue of $264 million for fiscal 2009, the year ended 30 June 2009. Net income was $105 million, and diluted earnings per share $0.69. The figures are the company's own, from the 10-K it filed with the SEC on 29 August 2011.

Revenue
$264 million
FY2009FY2009
Operating margin
57.1%
FY2009FY2009
Net income
$105 million
FY2009FY2009
Diluted EPS
$0.69
FY2009FY2009

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2009Last 8 years
Revenue264
Cost of revenue55.9
Gross profit208
Gross margin78.8%
Research and development23.6
Selling, general and administrative33.7
Operating income151
Operating margin57.1%
Income tax50.1
Net income105
Net margin39.9%
Diluted EPS$0.69
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2009Last 8 years
Operating cash flow111
Capital expenditure6.6
Free cash flow105
Free cash flow margin39.7%
Cash from investing21.3
Cash from financing-119
Depreciation and amortisation7.8
Share-based compensation1.5
Buybacks90.6
Dividends paid28.2
Dividend per share$0.19
Diluted shares, weighted152m

Balance sheet

$ millionFY2009Last 8 years
Shareholders' equity456
Goodwill25.1
Intangible assets3.0
Cash and equivalents161
Other assets283
Total assets472

10-K for the year ended 30 June 2009, filed 29 August 2011: the filing.